The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53

Oncogene

Volumn 31, Issue 27, 2012, Pages 3265-3276

  Lee, S O ^a   Andey, T ^b   Jin, U H ^a   Kim, K ^a   Sachdeva, M ^b   Safe, S ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b FLORIDA A AND M UNIVERSITY   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

c DIMs; lung cancer; mTORC1; NR4A1; Nur77; TR3

Indexed keywords

1,1 BIS(3' INDOLYL) 1 (4 HYDROXYPHENYL)METHANE; ANTINEOPLASTIC AGENT; CELL NUCLEUS RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA; INDOLE DERIVATIVE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; NUCLEAR RECEPTOR NR41A; NUCLEAR RECEPTOR NUR77; PROTEIN P53; SURVIVIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE; GENE INACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SESTRIN 2 GENE; WILD TYPE;

AGED; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INDOLES; LUNG NEOPLASMS; MALE; MICE; MIDDLE AGED; NUCLEAR PROTEINS; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; PHENOLS; PROGNOSIS; PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

MURINAE;

EID: 84863722218     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.504     Document Type: Article

References (35)

1. Azoitei N, Pusapati GV,KlegerA,Moller P, KuferR,Genze F et al. (2010). Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours. Gut 59: 1316-1330.
2. Bjornsti MA, Houghton PJ. (2004). The TOR pathway: a target for cancer therapy. Nat Rev Cancer 4: 335-348. (Pubitemid 38579480)
3. Bras A, Albar JP, Leonardo E, de Buitrago GG, Martinez A. (2000). Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells. Cell Death Differ 7: 262-271. (Pubitemid 30192975)
4. Budanov AV, Karin M. (2008). p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTORC1 signaling. Cell 134: 451-460.
5. Chen L, Hu L, Chan TH, Tsao GS, Xie D, Huo KK et al. (2009). Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival. Hepatology 50: 122-129.
6. Chen L, Yuan YF, Li Y, Chan TH, Zheng BJ, Huang J et al. (2010). Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion. Gut 60: 534-543.
7. Chintharlapalli S, Burghardt R, Papineni S, Ramaiah S, Yoon K, Safe S. (2005). Activation of Nur77 by selected 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways. J Biol Chem 280: 24903-24914. (Pubitemid 40934582)
8. Cho SD, Lee SO, Chintharlapalli S, Abdelrahim M, Khan S, Yoon K et al. (2010). Activation of nerve growth factor-induced Ba by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth. Mol Pharmacol 77: 396-404.
9. Cho SD, Yoon K, Chintharlapalli S, Abdelrahim M, Pei P, Hamilton S et al. (2007). Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and independent pathways. Cancer Res 67: 674-683. (Pubitemid 46192207)
10. Gronemeyer H, Gustafsson JA, Laudet V. (2004). Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 3: 950-964. (Pubitemid 39534319)
11. Guertin DA, Sabatini DM. (2007). Defining the role of mTORC1 in cancer. Cancer Cell 12: 9-22.
12. Hay N, Sonenberg N. (2004). Upstream and downstream of mTORC1. Genes Dev 18: 1926-1945.
13. Ke N, Claassen G, Yu DH, Albers A, Fan W, Tan P et al. (2004). Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res 64: 8208-8212. (Pubitemid 39491757)
14. Kolluri SK, Bruey-Sedano N, Cao X, Lin B, Lin F, Han YH et al. (2003). Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells. Mol Cell Biol 23: 8651-8667. (Pubitemid 37433369)
15. Kolluri SK, Zhu X, Zhou X, Lin B, Chen Y, Sun K et al. (2008). A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell 14: 285-298.
16. Lee JH, Budanov AV, Park EJ, Birse R, Kim TE, Perkins GA et al. (2010a). Sestrin as a feedback inhibitor of TOR that prevents agerelated pathologies. Science 327: 1223-1228.
17. Lee SO, Abdelrahim M, Yoon K, Chintharlapalli S, Papineni S, Kim K et al. (2010b). Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth. Cancer Res 70: 6824-6836.
18. Lee SO, Chintharlapalli S, Liu S, Papineni S, Cho SD, Yoon K et al. (2009). p21 Expression is induced by activation of nuclear nerve growth factor-induced Ba (NGFI-Ba, Nur77) in pancreatic cancer cells. Mol Cancer Res 7: 1169-1178.
19. Li H, Kolluri SK, Gu J, Dawson MI, Cao X, Hobbs PD et al. (2000). Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 289: 1159-1164. (Pubitemid 30650723)
20. Li QX, Ke N, Sundaram R, Wong-Staal F. (2006). NR4A1, 2, 3-an orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis. Histol Histopathol 21: 533-540.
21. Lin B, Kolluri SK, Lin F, Liu W, Han YH, Cao X et al. (2004). Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116: 527-540. (Pubitemid 38264430)
22. Liu JJ, Zeng HN, Zhang LR, Zhan YY, Chen Y, Wang Y et al. (2010). A unique pharmacophore for activation of the nuclear orphan receptor Nur77 in vivo and in vitro. Cancer Res 70: 3628-3637.
23. Maruyama K, Tsukada T, Bandoh S, Sasaki K, Ohkura N, Yamaguchi K. (1995). Expression of NOR-1 and its closely related members of the steroid/thyroid hormone receptor superfamily in human neuroblastoma cell lines. Cancer Lett 96: 117-122.
24. Maxwell MA, Muscat GE. (2006). The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl Recept Signal 4: e002.
25. McKenna NJ, Cooney AJ, DeMayo FJ, Downes M, Glass CK, Lanz RB et al. (2009). Minireview: evolution of NURSA, the nuclear receptor signaling atlas. Mol Endocrinol 23: 740-746.
26. Milbrandt J. (1988). Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1: 183-188.
27. Pearen MA, Muscat GE. (2010). Minireview: nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol Endocrinol 24: 1891-1903.
28. Shaw RJ, Cantley LC. (2006). Ras, PI(3)K and mTORC1 signalling controls tumour cell growth. Nature 441: 424-430. (Pubitemid 44050136)
29. She QB, Halilovic E, Ye Q, Zhen W, Shirasawa S, Sasazuki T et al. (2010). 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors. Cancer Cell 18: 39-51.
30. Wu H, Lin Y, Li W, Sun Z, Gao W, Zhang H et al. (2010). Regulation of Nur77 expression by {beta}-catenin and its mitogenic effect in colon cancer cells. FASEB J 25: 192-205.
31. Yang Q, Guan KL. (2007). Expanding mTORC1 signaling. Cell Res 17: 666-681.
32. Zeng H, Qin L, Zhao D, Tan X, Manseau EJ, Van HM et al. (2006). Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity. J Exp Med 203: 719-729.
33. Zhan Y, Du X, Chen H, Liu J, Zhao B, Huang D et al. (2008). Cytosporone B is an agonist for nuclear orphan receptor Nur77. Nat Chem Biol 4: 548-556.
34. Zhang XK. (2007). Targeting Nur77 translocation. Expert Opin Ther Targets 11: 69-79.
35. Zhao BX, Chen HZ, Lei NZ, Li GD, Zhao WX, Zhan YY et al. (2006). p53 mediates the negative regulation of MDM2 by orphan receptor TR3. EMBO J 25: 5703-5715.